PEPTIMMUNE INC has a total of 76 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are BIOSTEED GENE EXPRESSION TECH CO LTD, DERMAGEN AB and BIOKAD AOZT.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | Canada | 9 | |
#3 | EPO (European Patent Office) | 9 | |
#4 | Republic of Korea | 6 | |
#5 | United States | 6 | |
#6 | Brazil | 5 | |
#7 | China | 5 | |
#8 | Israel | 5 | |
#9 | Australia | 4 | |
#10 | Mexico | 4 | |
#11 | Norway | 3 | |
#12 | New Zealand | 3 | |
#13 | African Regional Industrial Property Organization | 2 | |
#14 | Argentina | 1 | |
#15 | Japan | 1 | |
#16 | Morocco | 1 | |
#17 | Tunisia | 1 | |
#18 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms | |
#6 | Analysing materials | |
#7 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Yu Bei | 40 |
#2 | Rasmussen James | 40 |
#3 | Zanelli Eric | 39 |
#4 | Bonnin Dustan | 32 |
#5 | Krieger Jeff | 17 |
#6 | Johnson Keith | 16 |
#7 | Baldwin Sam | 16 |
#8 | Zhang Jianxin | 16 |
#9 | Strominger Jack L | 11 |
#10 | Wucherpfennig Kai W | 10 |
Publication | Filing date | Title |
---|---|---|
WO2009128948A1 | Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders | |
US2009275496A1 | Effective quantitation of complex peptide mixtures in tissue samples and improved therapeutic methods | |
KR20100096092A | Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes | |
EP2157980A2 | Methods for the directed expansion of epitopes for use as antibody ligands | |
US2009036653A1 | Methods for the directed expansion of epitopes for use as antibody ligands | |
CA2649296A1 | Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability | |
US2006189527A1 | Methods of treating disease with random copolymers | |
CN101052409A | Methods of treating disease with random copolymers | |
AU2005219876A1 | Methods and compositions for treatment of autoimmune diseases | |
CN101014355A | Methods and compositions for treatment of autoimmune diseases | |
US7084247B2 | Identification of self and non-self antigens implicated in autoimmune diseases |